LMU Researchers Create Functional Human Blood-Brain Barrier in Lab, Advancing Neurological Disease Research
Table of Contents
Researchers at the LMU Clinic in Munich, led by Prof. Dr. Dominik Paquet and Prof. Dr. Martin Dichgans of the Institute for Stroke and Dementia Research (ISD) (https://www.lmu-klinikum.de/isd),have successfully engineered a functioning human blood-brain barrier (BBB) from human stem cells in a laboratory setting. This breakthrough, detailed in the journal Nature Neuroscience by first authors Dr. Judit González Gallego and Dr. Katalin Todorov-Voelgyi (https://www.nature.com/), offers a crucial new tool for understanding and combating neurological diseases.
The progress addresses a meaningful challenge in drug development and basic neuroscience research, where the lack of accurate human models has historically hindered progress.
The challenge of Neurological Drug Development
Historically, the translation of promising drug candidates from animal studies to prosperous human treatments for neurological disorders has been remarkably low. Despite extensive clinical trials,only a small fraction of drugs showing promise in animal models ultimately receive approval for patient use. This low success rate underscores the need for more physiologically relevant experimental models that accurately reflect human biology and disease processes.
As noted in a 2022 review in Drug Discovery Today, the BBB is a major contributor to this challenge, as animal models often fail to replicate the complexity of the human BBB (https://doi.org/10.1016/j.drudis.2022.01.008).
Why a Human Blood-Brain Barrier Model is Crucial
Researchers require models based on human cells to:
* Better predict the effects and risks of potential new drugs.
* Decipher the genetic and molecular basis of brain diseases like Parkinson’s disease, Alzheimer’s disease, and stroke.
Understanding the Blood-Brain Barrier
The blood-brain barrier is a highly selective interface protecting the brain while ensuring it receives essential nutrients. It’s a complex system comprised of:
* Endothelial cells: Forming the innermost layer of blood vessel walls, creating a tight physical barrier.
* Smooth muscle cells: Providing structural support and regulating blood flow.
* Glial cells: Contributing to barrier function and immune response.
The BBB functions in two key ways:
* Passive Barrier: It acts as a nearly impermeable barrier, preventing the entry of many substances from the bloodstream into the brain.
* Active Transport: It selectively allows essential nutrients to pass through while actively blocking potentially harmful substances.
Disruptions to the BBB are increasingly recognized as playing a significant role in the development and progression of numerous neurological diseases. Understanding how and why the BBB fails is therefore critical for developing effective therapies.
Implications and Future Directions
This newly developed human BBB model provides a platform to investigate the role of BBB dysfunction in neurological diseases and to test potential therapeutic interventions with greater accuracy. Researchers can now study:
* How specific genes contribute to BBB integrity.
* The impact of different disease states on BBB function.
* The ability of drug candidates to cross the BBB and reach their targets in the brain.
The creation of this functional human BBB in vitro represents a significant step forward in neurological research, offering hope for accelerating the development of effective treatments for debilitating brain diseases. Future research will focus on refining the model to more closely mimic the complexity of the in vivo BBB and utilizing it to screen for novel therapeutic compounds.
Key Takeaways:
* LMU researchers have created a functioning human blood-brain barrier from human stem cells.
* This model addresses a critical need for more accurate human-based research tools in neurological disease.
* The BBB model will aid in understanding disease mechanisms and testing potential therapies.
* The research was published in the prestigious journal Nature Neuroscience.